Eilmeldung
Anthropic Fights Trump Administration Over AI Model Export ControlsTrump and Iran Reach Initial Agreement to End War, Reopen Strait of HormuzG7 Leaders Tackle Ukraine War, Middle East Crisis at SummitDC Voters Head to Polls for Mayor, Congressional Delegate PrimariesElection Conspiracy Theorist Wins Nevada GOP Secretary of State PrimaryIsar Aerospace Faces New Delays in Spectrum Rocket Test FlightsFormer Louisville Officer Charged with Manslaughter in Fatal ShootingGoogle CEO Sundar Pichai Faces Student Protest at Stanford CommencementFormer ICE Acting Director Todd Lyons Hired by Defense ContractorGeorgia GOP Primary Runoff Exposes Party DivisionsAnthropic Fights Trump Administration Over AI Model Export ControlsTrump and Iran Reach Initial Agreement to End War, Reopen Strait of HormuzG7 Leaders Tackle Ukraine War, Middle East Crisis at SummitDC Voters Head to Polls for Mayor, Congressional Delegate PrimariesElection Conspiracy Theorist Wins Nevada GOP Secretary of State PrimaryIsar Aerospace Faces New Delays in Spectrum Rocket Test FlightsFormer Louisville Officer Charged with Manslaughter in Fatal ShootingGoogle CEO Sundar Pichai Faces Student Protest at Stanford CommencementFormer ICE Acting Director Todd Lyons Hired by Defense ContractorGeorgia GOP Primary Runoff Exposes Party Divisions
Newsgather

survival

Stabil176 Meldungen12 QuellenZuletzt aktualisiert: 39 dk önce
Verwandte Themenshark attackQueenslandCoogee BeachBaby JustinOne NationWorld CupCape VerdeSpain

Neueste Meldungen

Half of World's Children Face Overlapping Climate Hazards, Unicef Report Finds
Dringend
Welt·39 dk önceKI-Zusammenfassung

Half of World's Children Face Overlapping Climate Hazards, Unicef Report Finds

A Unicef report reveals that over a billion children globally face at least three overlapping climate hazards like heatwaves, storms, floods, and droughts. The report highlights the severe impact on children's health, education, and survival, using an example from Papua New Guinea where a washed-away bridge forces children to swim across a crocodile-infested river to reach school.

G
Guardian International
Revolution Medicines' Experimental Drug Doubles Survival in Advanced Pancreatic Cancer
In Entwicklung
Gesundheit·2 g önceKI-Zusammenfassung

Revolution Medicines' Experimental Drug Doubles Survival in Advanced Pancreatic Cancer

Revolution Medicines' experimental drug, daraxonrasib, has shown unprecedented success in treating advanced pancreatic cancer, doubling patient survival rates and significantly reducing the risk of death by 60% compared to standard chemotherapy. The drug, a first-in-class RAS(ON) inhibitor, targets specific RAS gene mutations and demonstrated a remarkable improvement in tumor shrinkage and patient quality of life, with a much lower incidence of severe side effects. The FDA has granted it expanded access and speedy review.

C
Cumhuriyet